GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hexima Ltd (ASX:HXL) » Definitions » Cash Ratio

Hexima (ASX:HXL) Cash Ratio : 18.05 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Hexima Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Hexima's Cash Ratio for the quarter that ended in Dec. 2023 was 18.05.

Hexima has a Cash Ratio of 18.05. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Hexima's Cash Ratio or its related term are showing as below:

ASX:HXL' s Cash Ratio Range Over the Past 10 Years
Min: 0.64   Med: 2.25   Max: 18.05
Current: 18.05

During the past 7 years, Hexima's highest Cash Ratio was 18.05. The lowest was 0.64. And the median was 2.25.

ASX:HXL's Cash Ratio is ranked better than
92.2% of 1525 companies
in the Biotechnology industry
Industry Median: 2.85 vs ASX:HXL: 18.05

Hexima Cash Ratio Historical Data

The historical data trend for Hexima's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hexima Cash Ratio Chart

Hexima Annual Data
Trend Jun08 Jun09 Jun10 Jun20 Jun21 Jun22 Jun23
Cash Ratio
Get a 7-Day Free Trial 8.62 2.70 0.87 0.64 12.58

Hexima Semi-Annual Data
Dec06 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.89 0.64 2.25 12.58 18.05

Competitive Comparison of Hexima's Cash Ratio

For the Biotechnology subindustry, Hexima's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hexima's Cash Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hexima's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Hexima's Cash Ratio falls into.



Hexima Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Hexima's Cash Ratio for the fiscal year that ended in Jun. 2023 is calculated as:

Cash Ratio (A: Jun. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=2.189/0.174
=12.58

Hexima's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1.913/0.106
=18.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hexima  (ASX:HXL) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Hexima Cash Ratio Related Terms

Thank you for viewing the detailed overview of Hexima's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hexima (ASX:HXL) Business Description

Traded in Other Exchanges
N/A
Address
84-90 Hotham Street, Corporate One, Preston, VIC, AUS, 3072
Hexima Ltd is a biotechnology company. The company is engaged in the research and development of plant-derived proteins and peptides for applications as human therapeutics.

Hexima (ASX:HXL) Headlines

From GuruFocus

Hexcel Declares Quarterly Dividend

By Business Wire Business Wire 10-24-2022

Hexcel Declares Quarterly Dividend

By Business Wire Business Wire 04-24-2023

Hexcel Reports 2023 Third Quarter Results

By Business Wire 10-23-2023

Hexcel Declares Quarterly Dividend

By Business Wire 07-24-2023

Hexcel Declares Quarterly Dividend

By Business Wire Business Wire 01-25-2023

Hexcel Schedules Third Quarter 2020 Earnings Release and Conference Call

By Business Wire Business Wire 10-01-2020

Top 5 4th Quarter Trades of Bouvel Investment Partners, LLC

By GuruFocus Research GuruFocus Editor 01-19-2023

Hexcel Reports 2023 Second Quarter Results

By Business Wire 07-24-2023